Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Mastech DigitalInformation Services GroupTransAtlantic CapitalBlackRock Capital InvestmentAvalon GloboCare
SymbolNYSEAMERICAN:MHHNASDAQ:IIIOTCMKTS:TACINASDAQ:BKCCNASDAQ:AVCO
Price Information
Current Price$16.98$4.31$0.20$3.65$0.99
52 Week RangeN/ABuyN/AN/AN/A
MarketRank™
Overall Score1.41.30.41.00.8
Analysis Score0.01.30.00.00.0
Community Score2.32.92.12.12.5
Dividend Score0.00.00.02.50.0
Ownership Score0.80.80.00.01.7
Earnings & Valuation Score3.81.30.00.60.0
Analyst Ratings
Consensus RecommendationN/ABuyN/AN/AN/A
Consensus Price TargetN/A$3.58N/AN/AN/A
% Upside from Price TargetN/A-17.05% downsideN/AN/AN/A
Trade Information
Market Cap$188.71 million$208.12 million$27.59 million$273.29 million$82.26 million
Beta0.630.7-1.511.730.57
Average Volume29,535231,51439,585407,092424,209
Sales & Book Value
Annual Revenue$193.57 million$265.76 millionN/A$78.12 million$1.55 million
Price / Sales1.000.78N/A3.4854.01
Cashflow$1.35 per share$0.34 per shareN/A$0.85 per shareN/A
Price / Cash12.5612.56N/A4.31N/A
Book Value$4.19 per share$1.89 per shareN/A$6.33 per share$0.06 per share
Price / Book4.052.28N/A0.5816.53
Profitability
Net Income$11.15 million$3.34 millionN/A$-6,890,000.00$-18,070,000.00
EPS$0.99$0.16N/A$0.59N/A
Trailing P/E Ratio19.7471.850.00N/A0.00
Forward P/E Ratio14.2728.737.93
P/E Growth0.561.92N/AN/AN/A
Net Margins5.16%1.37%N/A-160.86%-1,071.90%
Return on Equity (ROE)22.53%8.44%N/A10.19%-314.81%
Return on Assets (ROA)12.95%3.44%N/A5.32%-134.45%
Dividend
Annual PayoutN/AN/AN/A$0.40N/A
Dividend YieldN/AN/AN/A10.96%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A67.80%N/A
Years of Consecutive Dividend GrowthN/AN/AN/A1 YearsN/A
Debt
Debt-to-Equity Ratio0.07%0.80%N/A1.00%0.62%
Current Ratio1.81%2.48%N/A1.27%0.88%
Quick Ratio1.81%2.48%N/A1.27%0.88%
Ownership Information
Institutional Ownership Percentage16.69%48.31%N/A29.20%3.24%
Insider Ownership Percentage63.30%15.00%N/A1.60%73.40%
Miscellaneous
Employees1,5101,2871N/A7
Shares Outstanding11.42 million48.40 million136.61 million74.47 million84.41 million
Next Earnings Date5/5/2021 (Estimated)5/10/2021 (Confirmed)N/A4/29/2021 (Confirmed)5/13/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Avalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirusAvalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirus
proactiveinvestors.com - April 20 at 11:19 AM
Avalon GloboCare Corp. (NASDAQ:AVCO) Share Price Tumble Recently, But Trouble May Still Be AfootAvalon GloboCare Corp. (NASDAQ:AVCO) Share Price Tumble Recently, But Trouble May Still Be Afoot
stocksregister.com - April 17 at 1:28 PM
Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?
nasdaq.com - April 8 at 12:52 PM
Avalon GloboCare (NASDAQ:AVCO) Trading Down 2.7%Avalon GloboCare (NASDAQ:AVCO) Trading Down 2.7%
americanbankingnews.com - March 31 at 12:24 AM
Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center ...Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center ...
apnews.com - March 29 at 3:27 PM
Avalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR techAvalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR tech
proactiveinvestors.com - March 29 at 3:27 PM
Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ PlatformAvalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ Platform
finance.yahoo.com - March 29 at 3:27 PM
Avalon GloboCare expands its MIT co-development research program to fight cancer spreadAvalon GloboCare expands its MIT co-development research program to fight cancer spread
proactiveinvestors.com - March 22 at 1:21 PM
Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer MetastasisAvalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis
finance.yahoo.com - March 22 at 1:21 PM
Avalon GloboCare seeking to tap the power of cells to fight cancer and coronavirusAvalon GloboCare seeking to tap the power of cells to fight cancer and coronavirus
proactiveinvestors.com - March 15 at 2:26 PM
Avalon GloboCare Corp. (NASDAQ:AVCO) is an exciting stock to watchAvalon GloboCare Corp. (NASDAQ:AVCO) is an exciting stock to watch
stocksregister.com - February 7 at 10:47 PM
What Kind Of Shareholders Hold The Majority In Avalon GloboCare Corp.s (NASDAQ:AVCO) Shares?What Kind Of Shareholders Hold The Majority In Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shares?
finance.yahoo.com - January 23 at 12:21 PM
Avalon GloboCare issues update on its partnership with the Institute for Synthetic Bioarchitectures in Vienna, AustriaAvalon GloboCare issues update on its partnership with the Institute for Synthetic Bioarchitectures in Vienna, Austria
proactiveinvestors.com - December 30 at 1:40 PM
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular TherapeuticsAvalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular Therapeutics
finance.yahoo.com - December 30 at 1:40 PM
Avalon Globocare featured in article running in Nature’s Biopharma Dealmaker December editionAvalon Globocare featured in article running in Nature’s Biopharma Dealmaker December edition
proactiveinvestors.com - December 3 at 1:43 AM
Avalon GloboCares(NASDAQ:AVCO) Share Price Is Down 59% Over The Past Three Years.Avalon GloboCare's(NASDAQ:AVCO) Share Price Is Down 59% Over The Past Three Years.
finance.yahoo.com - November 17 at 7:25 AM
Avalon GloboCare Corp. Common Stock (AVCO)Avalon GloboCare Corp. Common Stock (AVCO)
nasdaq.com - October 30 at 3:22 PM
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-CareAvalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care
bloomberg.com - October 24 at 6:18 PM
The COVID-19 Pandemic Continues To Fuel Corporate IngenuityThe COVID-19 Pandemic Continues To Fuel Corporate Ingenuity
baystreet.ca - October 22 at 3:44 PM
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global ...Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global ...
apnews.com - October 22 at 10:42 AM
Avalon GloboCare and Adial Pharma rallies on strategic collaborationAvalon GloboCare and Adial Pharma rallies on strategic collaboration
seekingalpha.com - October 22 at 10:42 AM
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test DevicesAvalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
finance.yahoo.com - October 22 at 10:42 AM
Avalon GloboCare Provides Clinical Updates on Its...Avalon GloboCare Provides Clinical Updates on Its...
benzinga.com - October 3 at 1:20 PM
Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this yearAvalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year
proactiveinvestors.com - October 1 at 1:39 PM
Avalon GloboCare to add NHL patients to lead CAR T studyAvalon GloboCare to add NHL patients to lead CAR T study
seekingalpha.com - October 1 at 1:39 PM
DateCompanyBrokerageAction
8/10/2020Information Services GroupBarrington ResearchUpgrade
5/14/2020Information Services GroupCIBCBoost Price Target
5/12/2020Information Services GroupNoble FinancialReiterated Rating
3/25/2020BlackRock Capital InvestmentWells Fargo & CompanyReiterated Rating
1/16/2019BlackRock Capital InvestmentJPMorgan Chase & Co.Downgrade
(Data available from 4/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.